A Safety and Feasibility Study of Intraprocedural Physiology Measurements During Peripheral Endovascular Treatment
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 20
- 试验地点
- 2
- 主要终点
- Pressure wire measurements
研究概览
简要总结
Defining the role of intraprocedural physiology measurements in peripheral endovascular treatment
详细描述
Endovascular treatment for peripheral arterial disease is commonly performed for claudication or critical limb threatening ischaemia (ischaemic rest pain, foot ulcer or gangrene). Disease is generally identified using Ankle Brachial Pressure Index or Toe Brachial Pressure Index and then lesions delineated using Doppler ultrasound or CT angiography. Clinical severity is staged using absolute walking distance (metres) in claudicants or the Society for Vascular Surgery wIfI (wound, ischaemia, foot infection) score in critical limb threatening ischaemia patients.
Intra-procedural lesion assessment and quality control is currently performed anatomically using angiography alone, with a few centres using pullback pressures across a lesion to give supplementary trans-lesional gradients or intravascular ultrasound (IVUS) to give pre and post intervention diameter and vessel area measurements. No direct or quantitative assessment of flow, or pressure normalisation across lesions is currently performed during interventions to improve blood flow to the leg.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Basic Science
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —(Adult, Older Adult)
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •18 years of age
- •Peripheral arterial stenosis scheduled for endovascular treatment
排除标准
- •< 18 year of age
- •Unable to give informed consent
- •Estimated GFR ≤30 mL/min
- •Dialysis dependent
- •Unable to receive antiplatelets or periprocedural anticoagulation
- •Pregnancy or breastfeeding
- •Contraindication to adenosine (severe asthma or COPD)
- •WIfI ulcer score <2 (no exposed bone)
- •WIfI infection score <2 (skin and subcutaneous tissues only)
- •WIfI gangrene score <3 (limited to digits)
- •COVID-19 positive
- •NYHA IV heart failure
- •Contra-indication to adenosine including arrhythmia, asthma or allergy
结局指标
主要结局
Pressure wire measurements
时间窗: 12 months
次要结局
未报告次要终点
